Smart-Money SignalDistribution · 26/100— Insiders are net sellers over 90 days (-$46.8M, 60 sales vs 0 buys)
Revenue$185.2M
Net Income$1.7M
EPS$0.00
Gross Margin85.7%
Price Performance
Historical data including institutional events
Company Profile
B
Bradley Campbell
CEO & Executive Director
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
